{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:18:21Z","timestamp":1785860301129,"version":"3.56.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1097\/01.mbc.0000224852.42625.0d","type":"journal-article","created":{"date-parts":[[2006,5,1]],"date-time":"2006-05-01T08:01:54Z","timestamp":1146470514000},"page":"311-316","source":"Crossref","is-referenced-by-count":3,"title":["The use of recombinant\u2013activated factor VII in von Willebrand disease: a case series"],"prefix":"10.1097","volume":"17","author":[{"given":"Mario","family":"von Depka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murtada","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Blatn\u0177","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Smejkal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Vdovin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210203","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand's disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"key":"R2-13-20210203","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1055\/s-0038-1646168","article-title":"von Willebrand factor: structure and function","volume":"70","author":"Meyer","year":"1993","journal-title":"Thromb Haemost"},{"key":"R3-13-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-199701000-00001","article-title":"von Willebrand disease","volume":"76","author":"Nichols","year":"1997","journal-title":"Medicine (Baltimore)"},{"key":"R4-13-20210203","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1055\/s-0037-1614330","article-title":"Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation","volume":"82","author":"Castaman","year":"1999","journal-title":"Thromb Haemost"},{"key":"R5-13-20210203","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2516.2001.00498.x","article-title":"Hemophilia Research Society of North America. Management of von Willebrand disease: a survey on current clinical practice from the haemophilia centres of North America","volume":"7","author":"Cohen","year":"2001","journal-title":"Haemophilia"},{"key":"R6-13-20210203","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1056\/NEJM198310063091402","article-title":"Platelet aggregation induced by 1-desamino-8-D-arginine vasopressin (DDAVP) in Type IIB von Willebrand's disease","volume":"309","author":"Holmberg","year":"1983","journal-title":"N Engl J Med"},{"key":"R7-13-20210203","first-page":"574","article-title":"Congenital bleeding disorders.","volume":"559-","author":"Rick","year":"2003","journal-title":"Hematology (Am Soc Hematol Educ Program)"},{"key":"R8-13-20210203","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1046\/j.1365-2516.2002.00678.x","article-title":"DDAVP nasal spray for treatment of menorrhagia in women with inherited bleeding disorders: a randomized placebo-controlled crossover study","volume":"8","author":"Kadir","year":"2002","journal-title":"Haemophilia"},{"key":"R9-13-20210203","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/262141a0","article-title":"Precipitating antibodies in von Willebrand's disease","volume":"262","author":"Mannucci","year":"1976","journal-title":"Nature"},{"key":"R10-13-20210203","first-page":"348","article-title":"Posttransfussion anaphylactic reactions in a patient with severe von Willebrand disease: role of complement and alloantibodies to von Willebrand factor","volume":"125","author":"Bergamaschini","year":"1995","journal-title":"J Lab Clin Med"},{"key":"R11-13-20210203","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0025-6196(11)62333-1","article-title":"Acquired von Willebrand disease","volume":"77","author":"Kumar","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"R12-13-20210203","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1046\/j.1537-2995.2003.00550.x","article-title":"Management of severe VWD with cryoprecipitate collected by repeated apheresis of a single dedicated donor","volume":"43","author":"Pomper","year":"2003","journal-title":"Transfusion"},{"key":"R13-13-20210203","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000462547","article-title":"Effectiveness of high-dose intravenous gamma globulin therapy in acquired von Willebrand's disease","volume":"67","author":"van Genderen","year":"1994","journal-title":"Vox Sang"},{"key":"R14-13-20210203","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ajh.2830410212","article-title":"Effectiveness of high-dose intravenous immunoglobulin in a case of acquired von Willebrand syndrome with chronic melena not responsive to desmopressin and factor VIII concentrate","volume":"41","author":"Castaman","year":"1992","journal-title":"Am J Hematol"},{"key":"R15-13-20210203","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2141.1993.tb03074.x","article-title":"Gastro-intestinal bleeding in acquired von Willebrand's disease: efficacy of high-dose immuno-globulin where substitution treatments failed","volume":"84","author":"White","year":"1993","journal-title":"Br J Haematol"},{"key":"R16-13-20210203","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2141.1992.tb04610.x","article-title":"Efficacy of high-dose intravenous gammaglobulin in the management of acquired von Willebrand's disease during orthopaedic surgery","volume":"82","author":"Gross","year":"1992","journal-title":"Br J Haematol"},{"key":"R17-13-20210203","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ajh.10074","article-title":"Acquired von Willebrand disease \u2014 hemostatic management of major orthopedic surgery with high-dose immunoglobulin, desmopressin, and continuous factor concentrate infusion","volume":"70","author":"Frank","year":"2002","journal-title":"Am J Hematol"},{"key":"R18-13-20210203","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1365-2141.2003.04286.x","article-title":"The use of recombinant factor VIIa in children with inherited platelet function disorders","volume":"121","author":"Almeida","year":"2003","journal-title":"Br J Haematol"},{"key":"R19-13-20210203","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/BF03018648","article-title":"Successful treatment using recombinant factor VIIa for severe bleeding post cardiopulmonary bypass","volume":"50","author":"Naik","year":"2003","journal-title":"Can J Anaesth"},{"key":"R20-13-20210203","first-page":"431","article-title":"Recombinant activated factor VII for adjunctive hemorrhage control in trauma","volume":"51","author":"Martinowitz","year":"2001","journal-title":"J Trauma"},{"key":"R21-13-20210203","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1046\/j.1365-2141.2001.02878.x","article-title":"Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII","volume":"114","author":"Moscardo","year":"2001","journal-title":"Br J Haematol"},{"issue":"Suppl 1","key":"R22-13-20210203","first-page":"150","article-title":"Use of recombinant factor VIIa (NovoSeven) in the treatment of two patients with type III von Willebrand's disease and an inhibitor against von Willebrand factor","volume":"26","author":"Ciavarella","year":"1996","journal-title":"Haemostasis"},{"key":"R23-13-20210203","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1055\/s-0037-1613878","article-title":"Continuous infusion of recombinant factor VIIa (NovoSeven) in the treatment of a patient with type III von Willebrand's disease and alloantibodies against von Willebrand factor","volume":"83","author":"Grossmann","year":"2000","journal-title":"Thromb Haemost"},{"key":"R24-13-20210203","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00001721-200104000-00008","article-title":"Recurrent severe bleeding from gastrointestinal angiodysplasia in a patient with von Willebrand's disease, controlled with recombinant factor VIIa","volume":"12","author":"Meijer","year":"2001","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R25-13-20210203","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1309\/D0G0C96V05CJ5B4J","article-title":"Recombinant factor VIIa in the treatment of bleeding","volume":"121","author":"Midathada","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"R26-13-20210203","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1365-2141.2004.05171.x","article-title":": clinical experiences in the investigational use of rFVIIa in the management of severe haemorrhage [Letter].","volume":"127","author":"Kessler","year":"2004","journal-title":"Br J Haematol"},{"key":"R27-13-20210203","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/00003246-200106000-00038","article-title":"Effects of different plasma substitutes on blood coagulation: a comparative review","volume":"29","author":"de Jonge","year":"2001","journal-title":"Crit Care Med"},{"key":"R28-13-20210203","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1365-2257.2004.00632.x","article-title":"Evaluation of primary haemostasis in people with neurofibromatosis type 1","volume":"26","author":"Favaloro","year":"2004","journal-title":"Clin Lab Haematol"},{"key":"R29-13-20210203","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.ATV.0000047645.37970.AB","article-title":"Mechanism of action of high-dose factor VIIa: points of agreement and disagreement","volume":"23","author":"Monroe","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R30-13-20210203","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood.V94.11.3951","article-title":"Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia","volume":"94","author":"Poon","year":"1999","journal-title":"Blood"},{"key":"R31-13-20210203","first-page":"981","article-title":"A patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant factor VIIa","volume":"75","author":"Tengborn","year":"1996","journal-title":"Thromb Haemost"},{"key":"R32-13-20210203","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1055\/s-0037-1613884","article-title":"Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thrombasthenia undergoing invasive procedures","volume":"83","author":"d'Oiron","year":"2000","journal-title":"Thromb Haemost"},{"key":"R33-13-20210203","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0037-1963(01)90148-9","article-title":"Recombinant factor VIIa (Novoseven) and the safety of treatment","volume":"38","author":"Roberts","year":"2001","journal-title":"Semin Hematol"},{"key":"R34-13-20210203","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1538-7836.2004.00759.x","article-title":"Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors","volume":"2","author":"Abshire","year":"2004","journal-title":"J Thromb Haemost"}],"container-title":["Blood Coagulation &amp; Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001721-200606000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:21:35Z","timestamp":1785856895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-200606000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mbc.0000224852.42625.0d","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}